Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The oncoprotein phenotype of plasma cells from patients with multiple myeloma.

Leukemia & lymphoma - 1 Dec 1994

Brown R D, Pope B, Luo X F, Gibson J, Joshua D

Abstract excerpt

The expression of 6 different oncoproteins and 2 tumour suppressor gene products in the plasma cells of 63 bone marrow samples was used to determine a profile of the oncogenic phenotype of patients with multiple myeloma. Dual label flow cytometry after periodatelysine paraformaldehyde fixation was used to detect cell surface phenotype and intracellular protein expression simultaneously. The normal range for both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Flow Cytometry
Share to Gene Expression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, Tumor Suppressor

Share to In Situ Hybridization

Share to Oncogenes

Share to Phenotype

Share to RNA, Messenger

Source

Identifiers

PMID: 7696921
DOI: 10.3109/10428199409114152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The oncoprotein phenotype of plasma cells from patients with multiple myeloma.PMID 7696921Read ↗

Disease progression in patients with multiple myeloma is associated with a concurrent alteration in the expression of both oncogenes and tumour suppressor genes and can be monitored by the oncoprotein phenotype.Semantic proximity Read ↗

The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.Semantic proximity Read ↗

Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.Semantic proximity Read ↗

Genetic Abnormalities and Patterns of Antigenic Expression in Multiple MyelomaSemantic proximity Read ↗

Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myeloma.Semantic proximity Read ↗

Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III TrialSemantic proximity Read ↗

A Transgenic Mouse Model of Plasma Cell Malignancy Shows Phenotypic, Cytogenetic, and Gene Expression Heterogeneity Similar to Human Multiple MyelomaSemantic proximity Read ↗

Phenotypic characterization of the human myeloma cell growth fraction.Semantic proximity Read ↗

The generation and regulation of functional diversity of malignant plasma cells.Semantic proximity Read ↗

Mechanisms of the escape phase of myeloma.Semantic proximity Read ↗

Multiple myeloma: the cells of origin--a two-way street.Semantic proximity Read ↗

B-cell surface phenotypes of proliferating myeloma cells: target antigens for immunotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.